Skip to content
10-Q

Quarterly Report

Voyager Therapeutics, Inc. VYGR

0001558370-25-010511

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 55.47M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.67M sh
Shares Diluted Q2 2025 · Jun 30, 2025 58.51M sh
Shares Diluted Q2 2025 · Jun 30, 2024 57.72M sh
Shares Diluted Q2 2025 · Jun 30, 2024 57.42M sh
Capex Q2 2025 · Jun 30, 2025 $1.76M
Capex Q2 2025 · Jun 30, 2024 $3.11M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$71.16M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $27.19M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $43.94M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $71.37M
Stockholders Equity Q2 2025 · Jun 30, 2025 $243.94M
Stockholders Equity Q2 2025 · Mar 31, 2025 $272.7M
Stockholders Equity Q2 2025 · Dec 31, 2024 $299.76M
Stockholders Equity Q2 2025 · Jun 30, 2024 $335.42M
Stockholders Equity Q2 2025 · Mar 31, 2024 $340.89M
Stockholders Equity Q2 2025 · Dec 31, 2023 $236.32M
Current Liabilities Q2 2025 · Jun 30, 2025 $41.98M
Current Liabilities Q2 2025 · Dec 31, 2024 $49.79M
Total Liabilities Q2 2025 · Jun 30, 2025 $78.16M
Total Liabilities Q2 2025 · Dec 31, 2024 $93.29M
Current Assets Q2 2025 · Jun 30, 2025 $227.89M
Current Assets Q2 2025 · Dec 31, 2024 $276.81M
Total Assets Q2 2025 · Jun 30, 2025 $322.1M
Total Assets Q2 2025 · Dec 31, 2024 $393.05M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.57
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.10
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.18
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.37
Eps Basic Q2 2025 · Jun 30, 2025 −$0.57
Eps Basic Q2 2025 · Jun 30, 2025 −$1.10
Eps Basic Q2 2025 · Jun 30, 2024 −$0.18
Eps Basic Q2 2025 · Jun 30, 2024 −$0.37
Sga Expense Q2 2025 · Jun 30, 2025 $10.5M
Sga Expense Q2 2025 · Jun 30, 2025 $20.14M
Sga Expense Q2 2025 · Jun 30, 2024 $10.15M
Sga Expense Q2 2025 · Jun 30, 2024 $18.76M
Rd Expense Q2 2025 · Jun 30, 2025 $31.33M
Rd Expense Q2 2025 · Jun 30, 2025 $62.86M
Rd Expense Q2 2025 · Jun 30, 2024 $34.45M
Rd Expense Q2 2025 · Jun 30, 2024 $61.54M
Net Income Q2 2025 · Jun 30, 2025 −$33.38M
Net Income Q2 2025 · Jun 30, 2025 −$64.4M
Net Income Q2 2025 · Mar 31, 2025 −$31.02M
Net Income Q2 2025 · Jun 30, 2024 −$10.14M
Net Income Q2 2025 · Jun 30, 2024 −$21.47M
Net Income Q2 2025 · Mar 31, 2024 −$11.33M
Operating Income Q2 2025 · Jun 30, 2025 −$36.63M
Operating Income Q2 2025 · Jun 30, 2025 −$71.32M
Operating Income Q2 2025 · Jun 30, 2024 −$15.03M
Operating Income Q2 2025 · Jun 30, 2024 −$31.21M
Revenue Q2 2025 · Jun 30, 2025 $5.2M
Revenue Q2 2025 · Jun 30, 2025 $11.67M
Revenue Q2 2025 · Jun 30, 2024 $29.58M
Revenue Q2 2025 · Jun 30, 2024 $49.09M